Literature DB >> 1642892

Subtractive immunization techniques for the production of monoclonal antibodies to rare antigens.

C V Williams1, C L Stechmann, S C McLoon.   

Abstract

Traditional techniques for the production of monoclonal antibodies usually result in generation of monoclonal antibodies to immunodominant molecules. To enhance the production of monoclonal antibodies to rare or less immunodominant antigens, subtractive immunization techniques have been employed. This study compared the ability of several subtractive immunization techniques to suppress the immune system to a given antigen. Neonatal tolerization, chemical immunosuppression with cyclophosphamide, a combination of the two and various permutations of these techniques were compared. The results from this study indicated that chemical immunosuppression with cyclophosphamide was the most effective subtractive immunization technique and that the cyclophosphamide regime employed was a critical determinant in the success of chemical immunosuppression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1642892

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  11 in total

1.  Placental expression of the nonclassical MHC class I molecule Mamu-AG at implantation in the rhesus monkey.

Authors:  I I Slukvin; D P Lunn; D I Watkins; T G Golos
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

2.  Isolation of mouse pancreatic alpha, beta, duct and acinar populations with cell surface markers.

Authors:  Craig Dorrell; Maria T Grompe; Fong Cheng Pan; Yongping Zhong; Pamela S Canaday; Leonard D Shultz; Dale L Greiner; Chris V Wright; Philip R Streeter; Markus Grompe
Journal:  Mol Cell Endocrinol       Date:  2011-04-22       Impact factor: 4.102

3.  Search for the molecular basis of morphological variation in Mycobacterium avium.

Authors:  S Prinzis; B Rivoire; P J Brennan
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

4.  Surface markers for the murine oval cell response.

Authors:  Craig Dorrell; Laura Erker; Kelsea M Lanxon-Cookson; Stephanie L Abraham; Tristan Victoroff; Simon Ro; Pamela S Canaday; Philip R Streeter; Markus Grompe
Journal:  Hepatology       Date:  2008-10       Impact factor: 17.425

5.  Generation of monoclonal antibodies specific for cell surface molecules expressed on early mouse endoderm.

Authors:  Paul Gadue; Valerie Gouon-Evans; Xin Cheng; Ewa Wandzioch; Kenneth S Zaret; Markus Grompe; Philip R Streeter; Gordon M Keller
Journal:  Stem Cells       Date:  2009-09       Impact factor: 6.277

6.  Human thymic MR1-restricted MAIT cells are innate pathogen-reactive effectors that adapt following thymic egress.

Authors:  M C Gold; T Eid; S Smyk-Pearson; Y Eberling; G M Swarbrick; S M Langley; P R Streeter; D A Lewinsohn; D M Lewinsohn
Journal:  Mucosal Immunol       Date:  2012-06-13       Impact factor: 7.313

7.  Monoclonal Antibodies Reveal Dynamic Plasticity Between Lgr5- and Bmi1-Expressing Intestinal Cell Populations.

Authors:  Nicholas R Smith; John R Swain; Paige S Davies; Alexandra C Gallagher; Michael S Parappilly; Catherine Z Beach; Philip R Streeter; Ian A Williamson; Scott T Magness; Melissa H Wong
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-03-10

Review 8.  Rational monoclonal antibody development to emerging pathogens, biothreat agents and agents of foreign animal disease: The antigen scale.

Authors:  Jody D Berry
Journal:  Vet J       Date:  2005-09       Impact factor: 2.688

9.  Subtractive immunization yields monoclonal antibodies that specifically inhibit metastasis.

Authors:  P C Brooks; J M Lin; D L French; J P Quigley
Journal:  J Cell Biol       Date:  1993-09       Impact factor: 10.539

10.  Multiple Tolerization Subtractive Immunization (MTSI) Protocol: Effects on Mice and Monoclonal Antibody Specificity.

Authors:  Marina de Lima Fontes; Franciny Mara de Lima Neves; Kelvin Sousa Santos; Ana Marisa Fusco-Almeida; Maria José Soares Mendes Giannini; Sergio Luis Felisbino; Elenice Deffune; Andrei Moroz
Journal:  Front Immunol       Date:  2021-12-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.